0000791908-15-000091.txt : 20150717 0000791908-15-000091.hdr.sgml : 20150717 20150717180317 ACCESSION NUMBER: 0000791908-15-000091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150715 FILED AS OF DATE: 20150717 DATE AS OF CHANGE: 20150717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XOMA Corp CENTRAL INDEX KEY: 0000791908 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942756657 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2910 SEVENTH ST CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5106441170 MAIL ADDRESS: STREET 1: 2910 SEVENTH ST CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: XOMA LTD /DE/ DATE OF NAME CHANGE: 19990107 FORMER COMPANY: FORMER CONFORMED NAME: XOMA CORP /DE/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Varian John CENTRAL INDEX KEY: 0001416176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14710 FILM NUMBER: 15994703 MAIL ADDRESS: STREET 1: ARYX THERAPEUTICS,INC. STREET 2: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-07-15 0 0000791908 XOMA Corp XOMA 0001416176 Varian John C/O XOMA CORPORATION 2910 SEVENTH STREET BERKELEY CA 94710 1 1 0 0 CEO Common Shares 2015-07-15 4 M 0 10000.0 1.24 A 562414 D Common Shares 2015-07-15 4 S 0 10000.0 4.4869 D 552414 D Common Shares 18538 I by 401(k) Incentive Share Option (right to buy) 1.24 2015-07-15 4 M 0 10000.0 1.24 D 2022-01-04 Common Shares 10000 70392 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2014. This transaction was executed in multiple trades ranging at prices from $4.36 to $4.64. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Company or a security holder of the Company full information regarding the number of shares and prices at which the transactions were effected. Incentive Stock Option exercisable in conjunction with matching Non-Qualified Stock Option as to forty-eight (48) equal and consecutive monthly installments beginning one month after the date of grant. By: Russell J. Wood For: John Varian 2015-07-17